Mometasone Furoate Patent Expiration
Mometasone Furoate is Used for treating nasal polyps in adult patients who have had ethmoid sinus surgery using a corticosteroid-eluting (mometasone furoate) implant. It was first introduced by Organon Llc A Sub Of Organon And Co
Mometasone Furoate Patents
Given below is the list of patents protecting Mometasone Furoate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sinuva | US10232152 | Systems, devices, and method for treating a sinus condition | Nov 24, 2034 | Intersect Ent Inc |
| Sinuva | US10406332 | Systems, devices, and method for treating a sinus condition | Mar 13, 2034 | Intersect Ent Inc |
| Sinuva | US8763222 | Methods and devices for crimping self-expanding devices | Feb 08, 2032 | Intersect Ent Inc |
| Sinuva | US10357640 | Expandable devices and methods for treating a nasal or sinus condition | Oct 03, 2031 | Intersect Ent Inc |
| Sinuva | US8025635 | Device and methods for treating paranasal sinus conditions | Jun 12, 2027 | Intersect Ent Inc |
| Sinuva | US7544192 | Sinus delivery of sustained release therapeutics | Nov 29, 2026 | Intersect Ent Inc |
| Sinuva | US9585681 | Device and methods for treating paranasal sinus conditions | Apr 04, 2026 | Intersect Ent Inc |
| Sinuva | US7662141 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Sinuva | US7713255 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Sinuva | US7951130 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Sinuva | US7951131 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Sinuva | US7951133 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Sinuva | US8109918 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Asmanex Twisthaler |
US6503537 (Pediatric) | Preparation of powder agglomerates |
Sep 17, 2018
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US8173172 (Pediatric) | Preparation of powder agglomerates |
Sep 17, 2018
(Expired) | Organon Llc |
| Nasonex |
US6127353 (Pediatric) | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
Apr 03, 2018
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6503537 | Preparation of powder agglomerates |
Mar 17, 2018
(Expired) | Organon Llc |
| Asmanex Twisthaler | US8173172 | Preparation of powder agglomerates |
Mar 17, 2018
(Expired) | Organon Llc |
| Nasonex | US6127353 | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
Oct 03, 2017
(Expired) | Organon Llc |
| Asmanex Hfa | US6068832 | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
Aug 27, 2017
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US6240918 (Pediatric) | Powdered medication inhaler |
Aug 20, 2017
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6240918 | Powdered medication inhaler |
Feb 20, 2017
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US5829434 (Pediatric) | Inhaler for powdered medications |
May 03, 2016
(Expired) | Organon Llc |
| Asmanex Twisthaler | US5829434 | Inhaler for powdered medications |
Nov 03, 2015
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US5687710 (Pediatric) | Inhaler for powdered medications having spiral deagglomeration chamber |
May 18, 2015
(Expired) | Organon Llc |
| Asmanex Twisthaler | US5687710 | Inhaler for powdered medications having spiral deagglomeration chamber |
Nov 18, 2014
(Expired) | Organon Llc |
| Asmanex Hfa |
US5889015 (Pediatric) | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Hfa |
US6057307 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Hfa |
US6365581 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US5889015 (Pediatric) | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US6057307 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US6365581 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US6677322 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US6949532 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Nasonex |
US5837699 (Pediatric) | Use of mometasone furoate for treating upper airway passage diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Nasonex |
US6723713 (Pediatric) | Use of mometasone furoate for treating upper airway diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Hfa | US5889015 | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Hfa | US6057307 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Hfa | US6365581 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler | US5889015 | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6057307 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6365581 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6677322 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6949532 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Nasonex | US5837699 | Use of mometasone furoate for treating upper airway passage diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Nasonex | US6723713 | Use of mometasone furoate for treating upper airway diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US5394868 (Pediatric) | Inhalation device for powdered medicaments |
Dec 25, 2012
(Expired) | Organon Llc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Mometasone Furoate's patents.
Latest Legal Activities on Mometasone Furoate's Patents
Given below is the list recent legal activities going on the following patents of Mometasone Furoate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification Critical
| 12 Apr, 2024 | US8109918 |
| Mail O.P. Petition Decision | 12 Apr, 2024 | US8109918 |
| Mail-Record Petition Decision of Granted to Make Entity Status large | 09 Apr, 2024 | US8109918 |
| O.P. Petition Decision | 08 Apr, 2024 | US8109918 |
| Record Petition Decision of Granted to Make Entity Status large | 08 Apr, 2024 | US8109918 |
| Payment of Maintenance Fee under 1.28(c) | 13 Feb, 2024 | US8109918 |
| Petition Entered | 13 Feb, 2024 | US8109918 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 13 Feb, 2024 | US8109918 |
| Change in Power of Attorney (May Include Associate POA) Critical
| 09 Feb, 2024 | US8109918 |
| Email Notification Critical
| 09 Feb, 2024 | US8109918 |
Mometasone Furoate's Family Patents
